CSIMarket


Nurix Therapeutics Inc   (NASDAQ: NRIX)
Other Ticker:  
 

Nurix Therapeutics Inc

NRIX's Fundamental analysis








Looking into Nurix Therapeutics Inc growth rates, revenue grew by 11.26 % in I. Quarter 2025 from the same quarter a year ago. Ranking at No. 16

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.46 %

Nurix Therapeutics Inc net loss increased from $-42 millions, to $-56 millions in I. Quarter 2025,

More on NRIX's Growth


Nurix Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 37.01 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 17.12.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


More on NRIX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 482,197
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 5.76

Nurix Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 37.01 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 17.12.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Nurix Therapeutics Inc Price to Book Ratio is at 2.01 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

More on NRIX's Valuation

  Market Capitalization (Millions $) 966
  Shares Outstanding (Millions) 84
  Employees 117
  Revenues (TTM) (Millions $) 56
  Net Income (TTM) (Millions $) -208
  Cash Flow (TTM) (Millions $) 26
  Capital Exp. (TTM) (Millions $) -10
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 482,197
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 5.76

  Market Capitalization (Millions $) 966
  Shares Outstanding (Millions) 84
  Employees 117
  Revenues (TTM) (Millions $) 56
  Net Income (TTM) (Millions $) -208
  Cash Flow (TTM) (Millions $) 26
  Capital Exp. (TTM) (Millions $) -10





  Ratio
   Capital Ratio (MRQ) 6.26
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.28
  Asset Turnover Ratio (TTM) 0.1
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com